More than a year after the U.S. Food and Drug Administration approved Cycloset (bromocriptine mesylate) for treatment of type 2 diabetes, it’s now available at pharmacies. I updated my brief bromocriptine drug review of May 14, 2009.
I assume it’s the same bromocriptine that’s been available for years to treat Parkinson’s disease and acromegaly. Parlodel for Parkinson’s is sold as 2.5 and 5 mg tablets; Cycloset is 0.8 mg. [Update December 3, 2010: Cycloset is not the same formulation of bromocriptine used to treat other diseases. See first comment below.]